Female Functional Constipation Is Associated with Overactive Bladder Symptoms and Urinary Incontinence
Table 1
Patient characteristics.
Overall
Latent constipation
No constipation
p value
(41.4%)
(58.6%)
Age
68.6 ± 10.8
70.5 ± 10.5
67.2 ± 10.8
0.063
OABSS
3.9 ± 3.0
5.0 ± 3.6
3.2 ± 2.2
0.001
Moderate to severe OAB
29 (20.0)
20 (33.3)
9 (10.6)
0.001
Dry OAB
10 (6.9)
3 (5.0)
7 (8.2)
0.449
Wet OAB
25 (17.2)
19 (31.7)
6 (7.1)
<0.001
Diabetes
21 (14.5)
11 (18.3)
10 (11.8)
0.268
Hypertension
60 (41.4)
28 (46.7)
32 (37.6)
0.277
Cardiovascular disease
18 (12.4)
7 (11.7)
11 (12.9)
0.819
Hyperlipidemia
33 (22.8)
12 (20.0)
21 (24.7)
0.745
Ca blocker
45 (31.0)
23 (38.3)
22 (25.9)
0.110
ACEI/ARB
29 (20.0)
10 (16.7)
19 (22.4)
0.399
Antipsychotic
7 (4.8)
6 (10.0)
1 (1.2)
0.015
Diuretic
9 (6.2)
3 (5.0)
6 (7.1)
0.613
Data are (%) or mean SD. OABSS: Overactive Bladder Symptom Score, OAB: overactive bladder, ACEI: angiotensin-converting enzyme inhibitor, and ARB: angiotensin II receptor blocker.
